Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Navamedic ASA: Tom Rönnlund to step down as CEO

Oslo, Oct 1, 2018 - Navamedic ASA (OSE: NAVA) today announces that Tom Rönnlund has tendered his resignation as CEO of Navamedic ASA and will leave the company at the end of 2018 to take up a position with the Swedish probiotic company Probi AB. "Tom has been a driving force in the development of the company and leading it through challenging times. The platform Tom has built together with the team over the past three years puts us in a good position to further grow the company. On behalf of Navamedic, I want to express my thanks to Tom for his efforts and wish him success in his future

Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold symptom scales

Press Release October 1, 2018 Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold symptom scales Preliminary analysis of the Enzy-003 study on naturally occuring common cold, shows a significant reduction of disease duration and symptoms with ColdZyme usage, and less use of concomitant symptom-relieving self-medications, compared to a control group without ColdZyme intervention. In this single-blinded, prospective, and controlled  multicenter study, which was conducted at six German sites during the cold season 2018, 400

Invitation to a presentation of the Momentum Group’s Interim Report for the second quarter 2018/19

Momentum Group will publish its Interim Report for the second quarter of the financial year 2018/19 on Wednesday, 24 October 2018 at 08:00 a.m. CET. In conjunction with this, Momentum Group are pleased to issue this invitation to a webcast conference call in which CEO & President Ulf Lilius and CFO Niklas Enmark will present the report and answer any subsequent questions. The conference call and presentation are available on the web or by telephone in accordance with the details below. Questions may be asked both at the conference call and via the webcast. DATE:

#18-1760 Recalculation of reference value for certain instruments with Tesla Motors Inc. as underlying security

The reference value for certain certificates with Tesla Motors Inc. as underlying has been recalculated on Friday evening in accordance with the instruments final terms. This applies to the following instruments:Symbol: BEAR TESLA X2 CB Symbol: BEAR TESLA X3 CB Symbol: BEAR TESLA X6 C Symbol: BEAR TESLA X3 C Symbol: BEAR TESLA X6 CB Symbol: BEAR TESLA X5 CB Symbol: BEAR TESLA X6 CB 2 Symbol: BEAR TESLA X5 CB 2 Symbol: BEAR TESLA X8 C Symbol: BEAR TESLA X10 C The instruments will be traded under observation for the duration of this trading day. For more

RaySearch releases a new version of the RayCare oncology information system

RaySearch Laboratories AB (publ) has released RayCare 2B*, the latest version of the groundbreaking oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources.RayCare is developing rapidly with clinical input from some of the leading cancer centers worldwide, and this is the second of three releases during 2018. The first clinical version of RayCare was released in December 2017, and Iridium Cancer Network in Belgium started using it

Kimura Foundry adopts SinterCast process control technology

· SinterCast Mini-System 3000 to be installed during fourth quarter · Compacted Graphite Iron prototyping and niche volume production · Fourth SinterCast installation in Japan; twentieth installation in Asia[Shizuoka, Japan and Stockholm, 1 October 2018] – Kimura Foundry Company, Ltd., a ferrous cast metal foundry located in Japan, has entered into a technology supply agreement with the Swedish process control specialist SinterCast for Compacted Graphite Iron (CGI) product development, prototyping and niche volume production. Under the terms of the agreement, SinterCast will install a

SEMCON AUTOMATES PRODUCTION OF ECO-FRIENDLY FUEL CELLS

Semcon expands the partnership with fuel cell company Powercell with a view to upscale the company’s production of fuel cells with automation and robots. Fuel cells powered by hydrogen produce electricity and heat with no emissions other than water.Increasingly extensive electrification, primarily in the automotive sector, has resulted in a massive increase in interest in fuel cell technology. This project is part of Industry 4.0 for smarter factories. Powercell is able to streamline manufacturing, reduce costs and enhance quality thanks to an automated production environment. “As part

Asian customer to upgrade Prexision system

Mycronic has landed an order to upgrade a system to a full-scale Prexision-10 with expanded functionality. The upgrade will be implemented on a previously ordered Prexision-10 which was limited to production of G6/G8 photomasks. The order was booked in the third quarter and has a value in the span of USD 14-16 million. The implementation of the upgrade is planned to take place in the first quarter of 2019. ”Through this upgrade, the customer gains the capacity to meet increasing requirements for advanced photomasks for Generation 10,” says Charlott Samuelsson, Sr VP Business Area Pattern

Peab builds apartment buildings in Östersund

Peab has been commissioned to build 115 apartments in Östersund. The customer is Östersundshem and the contract is worth SEK 145 million.Project Tallbo entails building 115 apartments in five buildings along with a parking garage. The project is a turnkey contract. Construction will begin in October 2018 and final occupation is planned for January 2020. The project will be order registered in the third quarter of 2018. For further information, please contact: Sari Ekblom, Region Manager Peab, +46 70-339 57 47 Kajsa Jacobsson, Press Officer Peab, +46 725-33 34 84

Press accreditation for Stockholm International Film Festival is now open

The 29th annual Stockholm International Film Festival, one of the largest cultural events in Scandinavia, is only a few weeks away. From November 7th to November 18th, the festival will present over 150 films from 60 countries. Starting today, journalists and photographers can request press accreditation for this year’s festival.The accreditation gives you access to press screenings, press material and interview opportunities with visiting directors and actors. With your press pass, you are also eligible to attend regular festival screenings on weekdays until 5:00 pm (subject to

Environmental service provider acquires new companies: Delete buys Waterjet Stockholm and W-tech

Delete Sweden AB will acquire two more companies from European Hydro Demolition AB. “Waterjet Stockholm and W-tech will boost our presence in the Stockholm region. It is one of our growth areas, especially regarding the infrastructure sector, which is of great importance to the region,” says Lars-Gunnar Almryd, Managing Director of Delete Sweden.Only a few months after its acquisition of Waterjet Karlstad in June, Delete Sweden AB will now buy Waterjet Stockholm and W-tech, as well. The seller of all three companies is European Hydro Demolition AB.   “It seems natural and appropriate

Archer Limited: Grant of Restricted Stock Units

Hamilton, Bermuda (October 1, 2018) Archer Limited ("Archer" or the "Company") announces that the Board of Directors has granted restricted stock units (RSUs) to members of its management team. On Monday October 1, 2018 a total number of 1,927,500 RSUs were granted. The RSUs entitle the recipient to receive one common share for each RSU awarded. The RSUs are non-transferable and one third of the award will vest and be delivered on each of the first three anniversaries following the date of the award provided the employee remains employed at vesting. The total number of RSUs and options

PowerCell and Semcon in cooperation around automated manufacturing of fuel cells

PowerCell Sweden AB (publ) has initiated a cooperation with the international technology company Semcon around automated manufacturing of fuel cells using robots. The aim is to make the production more efficient and to reduce cost and improve the quality.The English version is an in house-translation. In case of any discrepancy, the Swedish text will prevail. During the first phase Semcon will deliver a test concept, production equipment and also provide installation and deployment of a semi-automatic test production. The robots will be delivered early October. Before the robots are

Renewed agreement between ABB and Wihlborgs paves the way for Fosie’s continued development

ABB is continuing its tenancy with Wihlborgs by signing a ten-year lease for 7,700 m² at the Boplatsen 3 property in Fosie, Malmö. The agreement will create the preconditions for the continued development of the property and the area.ABB has been a tenant at this address for more than 20 years, and the new, long lease agreement will give Wihlborgs the opportunity to modernise and develop the property. This will include the creation of a conference centre that can be used by ABB as well as other companies located in Fosie. The property already contains a popular breakfast and lunch

Bonava carries out investor transaction and sells 66 rental apartments in Ursvik

Bonava is selling a rental project in the Ursvik district of Sundbyberg, Stockholm, for a sales price of SEK 190 million. The purchaser is housing company Willhem and the transaction encompasses a total of 66 apartments in two tower blocks. The project is expected to be handed over to the customer and recognised in profit in the second and third quarters of 2019.- The development of well-planned, attractive rental apartments is important in our efforts to realise our vision of creating homes and happy neighbourhoods where people have the highest quality of life. We are delighted to have

Orexo internalizes contract field force in the US to further strengthen the commercial organization

Uppsala, Sweden – October 1, 2018 - Orexo AB (publ) today announces that the field representatives in the contracted field force have been offered direct employment with Orexo US Inc. starting October 1, 2018. The decision follows on the positive outcome in the patent litigation against Actavis, the continued revenue growth and significant improvement in the profit contribution from Orexo US Inc. during first half of 2018. To secure flexibility in the field force and the ability to rapidly adapt to changing market dynamics it has since the launch of Zubsolv® in the US in 2013 been an

Presentation at International IgA Nephropathy Network meeting highlighting supportive post-hoc analysis of the NEFIGAN study

Calliditas Therapeutics AB (publ) (”Calliditas”) today announced supportive post-hoc results from its clinical Phase 2b study NEFIGAN of the company’s lead candidate Nefecon, presented by Prof. Bengt Fellström at the International IgA Nephropathy Network meeting (IIgANN) in Buenos Aires, Argentina, on September 28, 2018.The oral presentation of the abstract – with the title Treatment of IgA nephropathy with Nefecon, a targeted‑release formulation of budesonide – extended posthoc results from the Nefigan trial – highlighted among other things, that Nefecon has a potential to become an

AstraZeneca PLC Announces Agreement with Cheplapharm for rights to Atacand in 28 European countries completed

1 October 2018 07:00 BST AstraZeneca has completed an agreement with Cheplapharm Arzneimittel GmbH (Cheplapharm) for the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in Europe. Under the terms of the agreement, AstraZeneca has received a payment of $200 million from Cheplapharm. A time-bound payment of $10 million as well as sales-contingent milestones will also be payable. The present value of the upfront and time-bound payments will be reported as Other Operating Income in the company'

Nobina AB (publ) to repurchase own shares

The Annual General Meeting resolved on 31 May 2018 to authorise the Board to decide to repurchase the company’s own shares. Based on this authorisation, the Board has decided to initiate a repurchase programme comprising not more than 1,246,654 shares. The aim of the repurchase programme is to meet the requirements arising under Nobina’s Share Saving Scheme, meaning securing delivery of the Performance Shares to the participants and securing and covering the costs for social fees that may arise.The repurchase programme will be implemented in accordance with the EU Market Abuse Regulation No

Share buy-backs in Telia Company during week 39 2018

During the period  September 24, 2018 - September 28, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2 105 000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018 and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Nordea’s re-domiciliation is completed

Nordea Bank Abp – Stock Exchange Release – Other information disclosed according to the rules of the Exchange As of today, 1 October 2018, Nordea is domiciled in Finland, a member of the European banking union, following the execution of the cross-border reversed merger between Nordea Bank AB (publ) and Nordea Bank Abp. As a result, the former parent company Nordea Bank AB (publ) has been dissolved, and all its assets and liabilities have been transferred to Nordea Bank Abp. Furthermore, 4,037,460,272 shares were issued to the former shareholders of Nordea Bank AB (publ) as merger

Psychotropic polypharmacy is common in Alzheimer’s disease

Up to half of people with Alzheimer’s disease (AD) use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland. Psychotropic drug use was more common among persons with Alzheimer’s disease already five years before the diagnosis, and the difference to comparison persons without AD increased at the time of diagnosis. Four years after the diagnosis, psychotropic drug use was three times more common in persons with AD than in comparison persons. Of psychotropic drugs, the use of antipsychotics

Selvaag Bolig ASA: sold 201 homes for NOK 861 million in third quarter

Selvaag Bolig sold 201 homes worth NOK 861 million in the third quarter, bringing total sales for the first nine months to 619 units with a combined value of NOK 2 509 million. "The market has been normal throughout the quarter, and we have sold well in all our projects - particularly in Greater Oslo. Signs of a market improvement can also be seen in the Stavanger area, and we believe this trend will continue," says CEO Olav Selvaag."Household purchasing power is high, and demand for homes remains strong. We have attractive housing projects with good locations in all the markets where

Establishment of Nomination Committee in IAR Systems Group AB

Stockholm, Sweden—September 30, 2018 — In accordance with the Annual General Meeting April 25, 2018, the Nomination Committee is composed to include Jonas Eixmann appointed by Andra AP-fonden, Mats Larsson appointed by Första AP-fonden and Jonas Wikström appointed by Stefan Skarin. Jonas Eixmann was appointed Chairman.The task of the nominating committee is to propose the Chairman at the annual general meeting 2019, Chairman and other members of the board as well as suggesting remuneration and other compensation for each of the board members. The Nominating Committee shall also propose

There are no items matching the current filter
There are no more items matching the current filter
Back to top